Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem[4] Imipenem,
Meropenem,
Methylprednisolone,
Ursodeoxycholic acid (Ursodeoxycholic acid)		[7] Imipenem ,
Methylprednisolone ,
Ursodiol (Ursodeoxycholic acid),
Methylprednisolone acetate ,
Meropenem ,
Imipenem ,
Meropenem 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
2Fenofibrate Combined With Ursodeoxycholic Acid[2] Fenofibrate,
Ursodeoxycholic acid (Ursodeoxycholic acid)		[2] Fenofibrate ,
Ursodiol (Ursodeoxycholic acid) 💬 		[2] NR1H4,
PPARA 💬 		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
3Fenofibrate in Combination With Ursodeoxycholic Acid[2] Fenofibrate,
Ursodeoxycholic acid (Ursodeoxycholic acid)		[2] Fenofibrate ,
Ursodiol (Ursodeoxycholic acid) 💬 		[2] NR1H4,
PPARA 💬 		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
4UDCA (Ursodeoxycholic acid)[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5Ursodeoxycholic acid[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[10] 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
6Ursodeoxycholic acid (UDCA)[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 94 💬
7Ursodeoxycholic acid (UDCA) 500 mg[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 46 💬
8Ursodeoxycholic Acid (URSO)[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
9Ursodeoxycholic Acid 300mg capsule[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
10Ursodeoxycholic Acid 300mg tablet[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
11Ursodeoxycholic Acid Capsules[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
12Ursodeoxycholic acid combination of immunosuppressive agents[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 95 💬
13Ursodeoxycholic acid combined with total glucosides of paeony[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
14Ursodeoxycholic acid only[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
15Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)[2] Methylprednisolone,
Ursodeoxycholic acid (Ursodeoxycholic acid)		[3] Methylprednisolone ,
Ursodiol (Ursodeoxycholic acid),
Methylprednisolone acetate 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬
16Ursodiol (ursodeoxycholic acid, UDCA)[1] Ursodeoxycholic acid (Ursodeoxycholic acid)[1] Ursodiol (Ursodeoxycholic acid) 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 97 💬